United Kingdom· GB-APID-44496111000001100
Imdylltra 1mg powder for concentrate and solution for solution for infusion vials
A tarlatamab product containing tarlatamab, registered in United Kingdom by Amgen Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Tarlatamab is registered in 12 of 19 countries.
Countries holding a registration under ATC L01FX33 (tarlatamab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Tarlatamab · ATC L01FX33
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Tarlatamab
- Manufacturer
- Amgen Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01FX33
- ATC class
- Tarlatamab
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin8715131028985
- gtin08715131028985
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tarlatamab in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumImdylltra 1 mgAmgen Europe
- SwitzerlandImdylltra 1 mg, Pulver für ein Konzentrat und Stabilisatorlösung zur Herstellung einer InfusionslösungAmgen Switzerland AG
- SpainIMDYLLTRA 1 MG POLVO PARA CONCENTRADO Y SOLUCIÓN PARA SOLUCION PARA PERFUSIONAmgen Europe B.V.
- FinlandImdylltraAmgen Europe B.V.
- IcelandImdylltraAmgen Europe B.V.*
- NorwayImdylltraAmgen Europe B.V.
- PolandIMDYLLTRAAmgen Europe B.V.
- SwedenIMDYLLTRA 1 mg Pulver till koncentrat och lösning till infusionsvätska, lösningAmgen Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Imdylltra
- Norway · Imdylltra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b7a63398-e0a6-406c-ad90-8b0c8b8c8bf3 GET /v1/drugs/b7a63398-e0a6-406c-ad90-8b0c8b8c8bf3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44496111000001100",
"desc": "Imdylltra 1mg powder for concentrate and solution for solution for infusion vials (Amgen Ltd)",
"form": "Powder and solution for solution for infusion",
"vpid": "44679711000001100",
"source": "dmd",
"vtm_id": "44643111000001100",
"strength": "1 mg",
"substance": "Tarlatamab",
"ingredient": "Tarlatamab",
"supplier_code": "3303701000001100"
}See everything about tarlatamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.